Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, May 29th. Zacks Research analyst R. Department now anticipates that the company will earn $0.56 per share for the quarter, down […]
Red Rock Resorts, Inc. (NASDAQ:RRR – Free Report) – Analysts at Zacks Research raised their Q2 2024 EPS estimates for Red Rock Resorts in a research note issued on Tuesday, May 28th. Zacks Research analyst M. Kaushik now expects that the company will post earnings per share of $0.43 for the quarter, up from their […]
Prothena Co. plc (NASDAQ:PRTA – Free Report) – Analysts at Zacks Research upped their Q2 2024 earnings per share (EPS) estimates for Prothena in a research report issued on Monday, May 27th. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will earn ($1.22) per share for the quarter, up from their previous […]
Citigroup Inc. (NYSE:C – Free Report) – Analysts at Zacks Research decreased their FY2024 earnings per share estimates for shares of Citigroup in a report issued on Monday, May 27th. Zacks Research analyst R. Department now expects that the company will post earnings of $5.88 per share for the year, down from their prior forecast […]
Matador Resources (NYSE:MTDR – Free Report) – Analysts at Zacks Research upped their Q3 2024 earnings per share estimates for Matador Resources in a report released on Monday, May 27th. Zacks Research analyst N. Banerjee now expects that the energy company will earn $2.00 per share for the quarter, up from their prior forecast of […]